Kalin Tochev, country manager of IQVIA Bulgaria, discusses the main trends taking place in the Bulgarian pharmaceutical sector and highlights the end-to-end approach that IQVIA offers to its clients to help them successfully navigate a dynamic environment.
Mr. Tochev, you have a quite unusual profile coming from different industries such as coffee trading. What factors triggered you to accept this new challenge in the healthcare world?
"It is important to show to the government the economic relevance of clinical research since it represents one of the main areas of investment of pharmaceutical companies."
